Product Information
AMOXICILLIN 125 MG/5 ML SUSP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0211 per ML under NDC 00143988801. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 19, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143988801
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLINApproval Type
Generic (ANDA)
FDA Application
ANDA065322FDA Approved
6/19/2006
TE Code
AB
On Market Since
6/19/2006
Pharmacological Classes
Price Statistics
The NADAC for AMOXICILLIN 125 MG/5 ML SUSP has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per ML |
|---|---|
| All-time high | $0.0228 (Jun 16, 2021) |
| All-time low | $0.0155 (Aug 19, 2020) |
| 52-week high | $0.0216 |
| 52-week low | $0.0201 |
| Median price | $0.0199 |
| Average price | $0.0197 |
| Largest weekly change | +22.4% (Sep 23, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOXICILLIN 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AMOXICILLIN 125 MG/5 ML SUSP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0211 per ML (NDC 00143988801), effective Sep 30, 2026.
How has the price of AMOXICILLIN 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AMOXICILLIN 125 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMOXICILLIN 125 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for AMOXICILLIN 125 MG/5 ML SUSP has ranged from a low of $0.0155 (Aug 19, 2020) to a high of $0.0228 (Jun 16, 2021), with a median of $0.0199 per ML.
Are there cheaper alternatives to AMOXICILLIN 125 MG/5 ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOXICILLIN 125 MG/5 ML SUSP, is $0.0176 per ML — about 17% below AMOXICILLIN 125 MG/5 ML SUSP.
Who manufactures AMOXICILLIN 125 MG/5 ML SUSP?
AMOXICILLIN 125 MG/5 ML SUSP (NDC 00143988801) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.